Ibuprofen Gen.Orph (Ibuprofen)

Ibuprofen Gen.Orph is an intravenous NSAID that acts on inflammatory pathways to manage several common clinical conditions.

• Pain: Provides rapid analgesia for acute moderate to severe pain when oral administration is not feasible.
• Fever: Reduces elevated body temperature associated with infectious or inflammatory processes.
• Inflammation: Decreases swelling and tissue inflammation in postoperative or trauma settings.

• Ibuprofen inhibits cyclooxygenase (COX‑1 and COX‑2) enzymes, blocking the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin synthesis diminishes nociceptor sensitization, lowers hypothalamic fever signals, and curtails the peripheral inflammatory response.

Intravenous ibuprofen may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild upset stomach occurring shortly after infusion.
• Headache: transient headache reported in some patients.
• Injection site pain: discomfort or erythema at the infusion site.
• Dizziness: occasional light‑headedness during or after administration.
• Mild hypotension: temporary drop in blood pressure during infusion.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical intervention.
• Severe bleeding: gastrointestinal or systemic hemorrhage.
• Acute renal failure: sudden loss of kidney function, especially in at‑risk patients.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Stevens‑Johnson syndrome: rare severe skin reaction.

When using Ibuprofen Gen.Orph, clinicians should observe several precautionary measures to minimize risk.

• Assess renal function: evaluate baseline kidney status and adjust use in renal impairment.
• Monitor hepatic function: avoid or limit use in patients with severe liver disease.
• Check for hypersensitivity: contraindicated in individuals with known allergy to ibuprofen or other NSAIDs.
• Use caution in cardiovascular disease: consider increased risk of thrombotic events.
• Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofen Gen.Orph can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Lithium: ibuprofen may raise lithium serum levels.
• Methotrexate: reduced clearance leading to toxicity.
• Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity.
• ACE inhibitors or ARBs: may diminish antihypertensive effect and worsen renal function.

Moderate Interactions (Monitor Closely)

• Antihypertensives (e.g., beta‑blockers, diuretics): possible reduction in blood pressure control.
• SSRIs or SNRIs: heightened bleeding tendency.
• Corticosteroids: increased risk of gastrointestinal ulceration.
• Oral hypoglycemics: potential alteration of blood glucose control.
• Diuretics: may exacerbate renal impairment when combined.